P
Piramal Pharma Ltd
NSE:PPLPHARMA
Piramal Pharma Ltd
NSE:PPLPHARMA
Price:
160.66
INR
0.74%
Market Cap:
₹212.6B
Cash Flow Statement
Cash Flow Statement
Piramal Pharma Ltd
Piramal Pharma Ltd
Currency: INR
| Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
1 198
|
0
|
3 417
|
1 832
|
|
| Depreciation & Amortization |
7 406
|
11 173
|
8 163
|
8 397
|
|
| Stock-Based Compensation |
275
|
0
|
480
|
0
|
|
| Other Non-Cash Items |
5 353
|
8 234
|
5 563
|
3 591
|
|
| Cash Taxes Paid |
1 568
|
3 434
|
3 344
|
2 382
|
|
| Cash Interest Paid |
4 696
|
6 872
|
4 474
|
3 946
|
|
| Change in Working Capital |
(3 911)
|
(14 150)
|
(8 221)
|
2 508
|
|
| Cash from Operating Activities |
10 045
N/A
|
6 810
-32%
|
8 923
+31%
|
15 974
+79%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(7 120)
|
(9 722)
|
(6 644)
|
(8 375)
|
|
| Other Items |
2 780
|
5 709
|
1 869
|
(339)
|
|
| Cash from Investing Activities |
(4 340)
N/A
|
(4 013)
+8%
|
(4 775)
-19%
|
(8 713)
-82%
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
10 500
|
10 502
|
0
|
12
|
|
| Net Issuance of Debt |
(9 886)
|
(10 193)
|
210
|
(1 271)
|
|
| Cash Paid for Dividends |
0
|
(145)
|
(145)
|
(186)
|
|
| Other |
(4 837)
|
(3 148)
|
(4 474)
|
(3 946)
|
|
| Cash from Financing Activities |
(4 224)
N/A
|
(2 984)
+29%
|
(4 408)
-48%
|
(5 393)
-22%
|
|
| Change in Cash | |||||
| Effect of Foreign Exchange Rates |
178
|
71
|
(109)
|
(278)
|
|
| Net Change in Cash |
1 660
N/A
|
(116)
N/A
|
(369)
-219%
|
1 589
N/A
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
2 925
N/A
|
(2 912)
N/A
|
2 279
N/A
|
7 599
+233%
|
|
Switch to:
Switch to:
See Also
Discover More
